RETINOIC ACID THERAPY FOR PROMYELOCYTIC LEUKAEMIA-Reference-Cited by-同舟云学术

RETINOIC ACID THERAPY FOR PROMYELOCYTIC LEUKAEMIA

Published:1989-09 Issue:8665 Volume:334 Page:746-747
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Chomienne Christine,Ballerini Paola,Balitrand Nicole,Amar Michèle,François Bernard Jean,Boivin Pierre,Thérèse Daniel Marie,Berger Roland,Castaigne Sylvie,Degos Laurent

Publisher

Elsevier BV

Subject

General Medicine

Reference6 articles.

1. Effect of 13 cis-retinoic acid on survival of patients with myelodysplastic syndromes;Clark;Lancet,1987

2. Terminal differentiation of human promyelocytic leukemic cells in primary culture m response to retinoic acid;Breitman;Blood,1981

3. Inefficacy of the synthetic aromatic retinoid etretinate and of its free add on the in vitro differentiation of leukemic cells;Chomienne;Leukemia Res,1986

4. Discrepancy between in vitro and in vivo inductions of differentiation by retinoids of human acute promyelocytic cells in relapse;Sampi;Leukemia Res,1985

5. Use of differentiation-inducing agents in the myelodysplastic syndrome and the acute non-lymphocytic leukemia;Hoffman;Am J Hematol,1988

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infrared Spectroscopy: A New Frontier in Hematological Disease Diagnosis;International Journal of Molecular Sciences;2023-11-30

2. Does the pursuit of scientific excellence serve or hamper translational medical research: an historical perspective from hematological malignancies;Blood Cancer Journal;2022-10-07

3. Emerging Cancer Epigenetic Mechanisms Regulated by All-Trans Retinoic Acid;Cancers;2020-08-14

4. Homocysteine, Thioretinaco Ozonide, and Oxidative Phosphorylation in Cancer and Aging: A Proposed Clinical Trial Protocol;Methods in Molecular Biology;2019

5. Identification of FDA-Approved Oncology Drugs with Selective Potency in High-Risk Childhood Ependymoma;Molecular Cancer Therapeutics;2018-06-20